SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-24-000068
Filing Date
2024-06-17
Accepted
2024-06-17 16:27:00
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20240331.htm   iXBRL 10-Q 820446
2 EX-31.1 exicureexhibit311-33124.htm EX-31.1 7748
3 EX-31.2 exicureexhibit312-33124.htm EX-31.2 7760
4 EX-32.1 exicureexhibit321-33124.htm EX-32.1 8228
  Complete submission text file 0001698530-24-000068.txt   5067313

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20240331.xsd EX-101.SCH 45592
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20240331_cal.xml EX-101.CAL 46721
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20240331_def.xml EX-101.DEF 164855
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20240331_lab.xml EX-101.LAB 567329
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20240331_pre.xml EX-101.PRE 370508
77 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20240331_htm.xml XML 519208
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 241048637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)